Lixin Certified Public Accountants Limited\'s special audit report on Guobang Pharmaceutical\'s 2023 non-operating capital occupation and other related capital transactions

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.